A novel five‐step synthetic route to 1,3,4‐oxadiazole derivatives with potent α‐glucosidase inhibitory potential and their in silico studies
- 23 September 2019
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 352 (12), e1900095
- https://doi.org/10.1002/ardp.201900095
Abstract
A series of new N‐aryl/aralkyl derivatives of 2‐methyl‐2‐{5‐(4‐chlorophenyl)‐1,3,4‐oxadiazole‐2ylthiol}acetamide were synthesized by successive conversions of 4‐chlorobenzoic acid (a) into ethyl 4‐chlorobenzoate (1), 4‐chlorobenzoylhydrazide (2) and 5‐(4‐chlorophenyl)‐1,3,4‐oxadiazole‐2‐thiol (3), respectively. The required array of compounds (6a–n) was obtained by the reaction of 1,3,4‐oxadiazole (3) with various electrophiles (5a–n) in the presence of DMF (N,N‐dimethylformamide) and sodium hydroxide at room temperature. The structural determination of these compounds was done by infrared, 1H‐NMR (nuclear magnetic resonance), 13C‐NMR, electron ionization mass spectrometry, and high‐resolution electron ionization mass spectrometry analyses. All compounds were evaluated for their α‐glucosidase inhibitory potential. Compounds 6a, 6c–e, 6g, and 6i were found to be promising inhibitors of α‐glucosidase with IC50 values of 81.72 ± 1.18, 52.73 ± 1.16, 62.62 ± 1.15, 56.34 ± 1.17, 86.35 ± 1.17, 52.63 ± 1.16 µM, respectively. Molecular modeling and ADME (absorption, distribution, metabolism, excretion) predictions supported the findings. The current synthesized library of compounds was achieved by utilizing very common raw materials in such a way that the synthesized compounds may prove to be promising drug leads.Keywords
This publication has 36 references indexed in Scilit:
- Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agentEuropean Journal of Medicinal Chemistry, 2013
- Synthesis, characterization and pharmacological study of 4,5-dihydropyrazolines carrying pyrimidine moietyEuropean Journal of Medicinal Chemistry, 2012
- Synthetic Approaches and Pharmacological Activity of 1,3,4-Oxadiazoles: A Review of the Literature from 2000–2012Molecules, 2012
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural DatabaseJournal of Chemical Information and Modeling, 2010
- Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agentsEuropean Journal of Medicinal Chemistry, 2009
- Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitorsRetrovirology, 2009
- Synthesis of 1-(4-phenoxyphenyl)-3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]propan-1-ones as safer anti-inflammatory and analgesic agentsJournal of the Serbian Chemical Society, 2008
- Structure validation by Cα geometry: ϕ,ψ and Cβ deviationProteins, 2003
- Bis heterocycles as potential chemotherapeutic agents.X. Synthesis of bis(4-arylthiosemicarbazido)-, bis(2-arylamino-1,3,4-thiadiazol-5-yl) and bis(4-aryl-1,2,4-triazolin-3-thione-5-yl)pentanes and related compoundsJournal of Heterocyclic Chemistry, 1990
- Studies of the Synthesis of Furan Compounds. XXIV. The Synthesis of 5-[2-(5-Nitro-2-furyl)-1-(4-nitrophenyl)vinyl]-1,3,4-oxadiazole and Its Related CompoundsBulletin of the Chemical Society of Japan, 1971